EHR-integrated rUTI Texting Platform

Last updated: August 30, 2024
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting

Phase

N/A

Condition

Urinary Tract Infections

Treatment

Usual care

EHR-integrated texting platform

EHR-integrated texting platform (Urotrust)

Clinical Study ID

NCT06035601
853917
  • Ages 18-100
  • Female
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI).

The main question it aims to answer is:

• can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care?

Participants enrolled onto the texting platform will:

• receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Provision of signed and dated informed consent form

  2. Stated willingness to comply with all study procedures and availability for theduration of the study

  3. Females who currently meet the criteria for recurrent UTIs

  4. Age 18 years or older

  5. Owns a mobile device with text messaging capability

  6. Ability to read and write English

  7. Currently receiving care from a provider in Penn Urogynecology or Penn Urology

Exclusion

Exclusion criteria:

  1. History of known multidrug resistant UTIs

  2. History of interstitial cystitis/bladder pain syndrome or current diagnosis ofchronic pelvic pain

  3. On continuous suppressive antibiotics currently

  4. Currently pregnant or within 6 weeks of pregnancy

  5. Transplant patient on immunosuppressive medication currently

  6. Practice of chronic self-catheterization

Study Design

Total Participants: 100
Treatment Group(s): 3
Primary Treatment: Usual care
Phase:
Study Start date:
March 07, 2024
Estimated Completion Date:
June 15, 2026

Connect with a study center

  • University of Pennsylvania

    Philadelphia, Pennsylvania 19104
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.